Kernel Health
Amara Okafor (@amara_builds) · On-device diagnostic models for low-connectivity clinics.
Every claim in this memo, checked against how well it holds up.
Company Snapshot
What the company does and where it sits in the market.
Kernel Health operates in Health AI (Lagos, NG, Pre-seed). On-device diagnostic models for low-connectivity clinics. Low-connectivity clinical AI is under-served; grant + payer tailwinds. SOM modest near-term, large by 2030.
Investment Hypotheses
The core bets underlying this memo, each traced to its evidence.
- Team quality: Substance is elite (novel quantization approach shipped, real clinic pilot). Naive LLM scoring under-rated her by 17 pts purely on English fluency; the Legibility-Bias Corrector removed that penalty.⟦ev-ao-repo⟧
- Market wedge: Low-connectivity clinical AI is under-served; grant + payer tailwinds. SOM modest near-term, large by 2030.
- Traction signal: Live pilot in 2 clinics⟦ev-ao-pilot⟧VERIFIED
- Defensibility: Idea survives; on-device constraint is a genuine moat where cloud can't reach.⟦ev-ao-repo⟧
- Founder credibility: Solo founder, self-taughtCLAIMED
SWOT
Strengths, weaknesses, opportunities, threats — shown only where evidence exists.
- Steelman-Your-Rival: Precisely mapped cloud-based incumbents and why connectivity kills them — real market command despite rough phrasing.
- Delegate-an-Analyst: Caught the planted error and rewrote the market-size line herself.
- Live pilot in 2 clinics⟦ev-ao-pilot⟧VERIFIED
- Founder axis improving: Substance is elite (novel quantization approach shipped, real clinic pilot). Naive LLM scoring under-rated her by 17 pts purely on English fluency; the Legibility-Bias Corrector removed that penalty.⟦ev-ao-repo⟧
- Market axis improving (bullish): Low-connectivity clinical AI is under-served; grant + payer tailwinds. SOM modest near-term, large by 2030.
- Hackathon Winner Cross-Match: Won an on-device health hackathon; repo showed production-grade quantization.
Problem & Product
The problem being solved and how the product addresses it.
Problem: Low-connectivity clinical AI is under-served; grant + payer tailwinds. SOM modest near-term, large by 2030.
Product: On-device diagnostic models for low-connectivity clinics. Idea survives; on-device constraint is a genuine moat where cloud can't reach.
Traction & KPIs
Traction and revenue signals, with unverified gaps flagged explicitly.
- Live pilot in 2 clinics⟦ev-ao-pilot⟧VERIFIED
- ARR: not applicable — pre-revenue stage
- Cap table: not disclosed
- Financials / P&L: unavailable at this stage
2 sourcesbehind the citations above — duplicates the inline ⟦refs⟧, expand to inspect the raw excerpt.
Three-Axis Verdict
never averagedFounder, market, and idea-fit scored independently — one weak axis can't be masked by a strong one.
Strong substance; advance to full diligence. Naive scoring would have wrongly passed — the bias corrector is the difference between funding merit and funding fluency.